Ctla4-binding protein peptide-linker masks
AssigneesCity of Hope, Thomas Jefferson University and Health System, Innovation Pillar
InventorsJohn WILLIAMS, Ulrich RODECK
Life of this patent
Estimating the term…
Loading patent…
AssigneesCity of Hope, Thomas Jefferson University and Health System, Innovation Pillar
InventorsJohn WILLIAMS, Ulrich RODECK
Estimating the term…
Provided herein are recombinant CTLA-4 binding proteins, which are, inter alia, useful for the treatment of cancer. The recombinant proteins provided herein are, inter alia, capable of binding CTLA-4 proteins on a tumor cell. In a first aspect, there is provided a recombinant CTLA-4 binding protein including (i) a CTLA-4 binding domain; (ii) a CTLA-4 binding domain masking peptide; and (iii) a cleavable peptide linker connecting the CTLA-4 binding domain masking peptide to the CTLA-4 binding domain. In another aspect, there is provided a dimerizing domain covalently attached to the CTLA-4 binding domain, wherein the binding protein domains are bound together.
A recombinant CTLA-4 binding protein comprising:
(canceled)
22-50. (canceled)
52-54. (canceled)
Dependencies are inferred from the claim text.